Synaptogenix grants 485,000 RSUs to directors and officers for spin-off and up-listing efforts

TAO Synergies Inc.

RSUs awarded to 8 individuals (including CEO, CFO, directors) totaling 485,000 shares.
Joshua N. Silverman (CEO) receives 90,000 RSUs; Dr. Daniel Alkon (Chief Scientific Officer) 80,000.
Vesting: 50% at 6-month anniversary, 50% at 1-year anniversary of July 13, 2021 grant date.
Grant rewards efforts on spin-off, Nasdaq up-listing, and June 2021 private placement financing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.